• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Vasc Surg . Characteristics of venous thromboembolism in COVID-19 patients: a multicenter experience from Northern Italy

tetano

Editor, Senior Moderator
Ann Vasc Surg


. 2020 Jul 13;S0890-5096(20)30598-7.
doi: 10.1016/j.avsg.2020.07.007. Online ahead of print.
Characteristics of venous thromboembolism in COVID-19 patients: a multicenter experience from Northern Italy


Enrico M Marone[SUP] 1 [/SUP], Giovanni Bonalumi[SUP] 2 [/SUP], Ruggiero Curci[SUP] 3 [/SUP], Aldo Arzini[SUP] 4 [/SUP], Simona Chierico[SUP] 5 [/SUP], Giulia Marazzi[SUP] 5 [/SUP], Domenico A Diaco[SUP] 4 [/SUP], Rosa Rossini[SUP] 5 [/SUP], Stefano Boschini[SUP] 5 [/SUP], Luigi F Rinaldi[SUP] 5 [/SUP]



Affiliations

Abstract

Objective: The liability of patients affected by novel coronavirus disease (COVID-19) to develop venous thromboembolic events (VTE) is widely acknowledged. However, many particulars of the interactions between the two diseases are still unknown. This study aims to outline the main characteristics of deep venous thrombosis (DVT) and pulmonary embolism (PE) in COVID-19 patients, based on experience of four high-volume COVID-19 hospitals in Northern Italy.
Methods: All cases of COVID-19 in-hospital patients undergoing duplex ultrasound (DUS) for clinically suspected DVT between March 1[SUP]st[/SUP] and April 25[SUP]th[/SUP] 2020 were reviewed. Demographics and clinical data of all patients with confirmed DVT were recorded. Computed Tomography Pulmonary Angiographies of the same population were also examined looking for signs of PE.
Results: of 101 DUS performed, 42 were positive for DVT, 7 for superficial thrombophlebitis and 24 for PE, 8 of which associated with a DVT. Most had a moderate (43.9%) or mild (16.9%) pneumonia. All venous districts were involved. Time of onset varied greatly, but diagnosis was more frequent in the first two weeks since in-hospital acceptance (73.8%). Most PEs involved the most distal pulmonary vessels, and two thirds occurred in absence of a recognizable deep vein thrombosis.
Conclusions: DVT, thrombophlebitis and PE are different aspects of COVID-19 procoagulant activity and they can arise regardless of severity of respiratory impairment. All venous districts can be involved, including the pulmonary arteries, where the high number and distribution of the thrombotic lesions without signs of DVT could hint a primitive thrombosis rather than embolism.
 
Back
Top Bottom